Surveying The Biosimilar Battlefield
The biosimilar market has been of particular interest to us in light of the high expectations set for Samsung Biologics Co., Ltd (207940 KS) Â and...
890 Views
HealthCare Global Enterprises (HCG)- A Niche Play in Burgeoning Indian Healthcare Sector
HealthCare Global Enterprises Limited (HCG IN) is a speciality healthcare provider with a focus on cancer and infertility treatment. It is the...
978 Views
Quick Note - Almost at the Finishing Line
Latest Update:Glass Lewis and ISS have advised Wuxi's shareholders to approve the offer from the consortium. We believe Shareholders will vote in...
590 Views
WuXi PharmaTech: How to Argue for a Few Dollars More
WuXi PharmaTech's recent placements of stock of its NEEQ-listed Syn-The-All Pharmaceutical Co. subsidiary have been at a substantially higher...
568 Views
WuXi's Chairman and Ally Bridge Offer $46/ADS in Going Private Bid
WuXi's Founder, Chairman and CEO, Dr. Ge Li and private equity firm Ally Bridge have made a non-binding offer to take the company private for...
711 Views